Annual Drug Patent Expiration for EPIDIOOLEX
Epidiolex is a drug marketed by Gw Res Ltd and included in one NDA. It is available from a single supplier. There are twenty-six patents protecting this drug.
Drug patent litigation for EPIDIOOLEX.
This drug has one hundred and thirty-eight patent family members in twenty-five countries.
The generic ingredient in EPIDIOOLEX is cannabidiol. One registered supplier for this compound. Additional details are available on the cannabidiol profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published in New patent for the drug Gw Res EPIDIOOLEX